Type 2 Diabetes-II: Pathogenesis, Diagnosis, and Treatment
A special issue of Molecules (ISSN 1420-3049). This special issue belongs to the section "Medicinal Chemistry".
Deadline for manuscript submissions: closed (31 March 2020) | Viewed by 13633
Special Issue Editor
Interests: chronic inflammation; non-alcoholic fatty liver disease; intestinal microbiota; diabetes; nutrition; artificial in-telligence; metabolism
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Recently, attempts to understand the type 2 diabetes, a pathological condition of sarcopenic obesity involving a decrease in skeletal muscle mass combined with an increase in visceral fat, have attracted attention.
The term “sarcopenia” was coined in 1988 by Dr. Irwin Rosenberg as age-related loss of skeletal muscle mass and skeletal muscle strength. At present, loss of skeletal muscle mass and skeletal muscle strength in various pathological conditions other than aging is regarded as important.
On the other hand, metabolic abnormalities, which occur with abdominal obesity or ectopic fat and are associated with diabetes, fatty liver, and cardiovascular diseases, now focus on the relationship with sarcopenia. In addition, many non-obese people with metabolic abnormalities, who are not obese according to their BMI, have been developing type 2 diabetes in Asia. These metabolic abnormalities are thought to be a cause of sarcopenic obesity, but the pathological condition has not been clarified yet. Moreover, treatment for sarcopenic obesity has also not been established.
This Special Issue aims to provide a forum for the dissemination of the latest information on pathogenesis, and treatment for sarcopenic obesity.
Prof. Dr. Masahide Hamaguchi
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Molecules is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- Sarcopenia
- Obesity
- Lean
- Sarcopenic obesity
- Fatty liver
- Diabetes
